ADVANCED — Sales to customers (Note 9)

Products & Services · Sales to customers (Note 9)

Johnson & Johnson ADVANCED — Sales to customers (Note 9) increased by 0.1% to $2.33B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $2.22B to $2.33B. Over 2 years (FY 2021 to FY 2024), ADVANCED — Sales to customers (Note 9) shows an upward trend with a 8.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2017
Last reportedQ3 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market adoption and successful commercialization of advanced product offerings, while a decrease may signal competitive pressure or product lifecycle maturity.

Detailed definition

This metric represents the total revenue generated from the Advanced product segment, reflecting the market demand for t...

Peer comparison

Comparable to segment-specific revenue reporting in medical device or pharmaceutical peers, often benchmarked against total segment revenue growth rates.

Metric ID: jnj_segment_advanced_sales_to_customers_note_9

Historical Data

16 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$2.24B$2.34B$2.29B$2.35B$2.29B$2.31B$2.32B$2.24B$2.33B$2.17B$2.28B$2.22B$2.30B$2.15B$2.33B$2.33B
QoQ Change+4.4%-2.0%+2.5%-2.3%+0.9%+0.2%-3.5%+4.2%-6.6%+5.0%-2.8%+3.8%-6.8%+8.5%+0.1%
YoY Change+2.5%-1.0%+1.2%-2.5%+0.7%+2.1%-4.7%-1.3%+2.0%+5.0%
Range$2.15B$2.35B
CAGR+1.1%
Avg YoY Growth+0.4%
Median YoY Growth+0.9%
Current Streak2 quarters growth

Frequently Asked Questions

What is Johnson & Johnson's advanced — sales to customers (note 9)?
Johnson & Johnson (JNJ) reported advanced — sales to customers (note 9) of $2.33B in Q3 2025.
How has Johnson & Johnson's advanced — sales to customers (note 9) changed year-over-year?
Johnson & Johnson's advanced — sales to customers (note 9) increased by 5.0% year-over-year, from $2.22B to $2.33B.
What is the long-term trend for Johnson & Johnson's advanced — sales to customers (note 9)?
Over 2 years (2021 to 2024), Johnson & Johnson's advanced — sales to customers (note 9) has grown at a 8.1% compound annual growth rate (CAGR), from $7.68B to $8.98B.
What does advanced — sales to customers (note 9) mean?
The total revenue earned from the company's Advanced product line.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.